Lee C S, Sun D, Kizu R, Hurley L H
Drug Dynamics Institute, College of Pharmacy, University of Texas, Austin 78712.
Chem Res Toxicol. 1991 Mar-Apr;4(2):203-13. doi: 10.1021/tx00020a013.
Analysis of the anomalous migration in electrophoretic mobilities of (+)-CC-1065-modified oligomers following ligation reveals that (+)-CC-1065 induces DNA bending and winding of the helix. (+)-CC-1065 is a potent antitumor antibiotic produced by Streptomyces zelensis. This drug selectively bonds covalently to N3 of adenine and lies in the minor groove of DNA, reacting in a highly sequence-selective manner. Structurally, (+)-CC-1065 consists of three subunits: two identical pyrroloindole units (subunits B and C) and a third subunit containing the DNA-reactive cyclopropane ring (subunit A). While the bonding reaction is the main determinant of DNA sequence selectivity of (+)-CC-1065, binding interactions between the inside edge substituents of the B and C subunits and the floor of the minor groove of DNA can modulate or fine tune this sequence selectivity, [Hurley, L. H., Lee, C.-S., McGovern, J. P., Mitchell, M. A., Warpehoski, M. A., Kelly, R. C., & Aristoff, P. A. (1988) Biochemistry 27, 3886-3892]. The A subunit of (+)-CC-1065 is responsible for the bending of DNA, and close van der Waals contacts between the inside edge of (+)-CC-1065 and the floor of the minor groove of DNA cause winding equivalent to about 1 base pair per alkylation site and stiffening of DNA. The magnitude of DNA bending induced by (+)-CC-1065 and related compounds is about 14-19 degrees, which is equivalent to that produced by an adenine-thymine tract of about 5-6 base pairs in length. Experiments using oligomers containing both an adenine tract and a unique (+)-CC-1065 bonding site approximately one helix turn apart demonstrate that the directionality of drug-induced bending is in toward the minor groove and the locus of bending is about 2-3 base pairs to the 5'-side of the covalently modified adenine. A circularization efficiency assay shows that the optimum size of circles produced by (+)-CC-1065 and related drugs is between 168 and 180 base pairs. These results are discussed in relation to the molecular basis of the DNA sequence selectivity of (+)-CC-1065, and the (+)-CC-1065-induced DNA bending is compared with the intrinsic bending associated with adenine tracts. Since (+)-CC-1065 induces effects on local DNA structure that appear similar to those produced naturally by adenine tracts and certain DNA binding proteins, the relevance of this phenomenon to biological effects of (+)-CC-1065 and related drugs is considered.
对连接后(+)-CC-1065修饰的寡聚物电泳迁移率异常变化的分析表明,(+)-CC-1065会诱导DNA弯曲和螺旋缠绕。(+)-CC-1065是由泽链霉菌产生的一种强效抗肿瘤抗生素。该药物选择性地与腺嘌呤的N3共价结合,并位于DNA的小沟中,以高度序列选择性的方式发生反应。从结构上看,(+)-CC-1065由三个亚基组成:两个相同的吡咯并吲哚单元(亚基B和C)以及第三个含有与DNA反应性环丙烷环的亚基(亚基A)。虽然键合反应是(+)-CC-1065对DNA序列选择性的主要决定因素,但B和C亚基内边缘取代基与DNA小沟底部之间的结合相互作用可以调节或微调这种序列选择性,[赫尔利,L.H.,李,C.-S.,麦戈文,J.P.,米切尔,M.A.,瓦尔佩霍斯基,M.A.,凯利,R.C.,&阿里斯托夫,P.A.(1988年)《生物化学》27,3886 - 3892]。(+)-CC-1065的A亚基负责DNA的弯曲,(+)-CC-1065内边缘与DNA小沟底部之间紧密的范德华接触导致每烷基化位点约相当于1个碱基对的缠绕以及DNA的刚性增强。(+)-CC-1065及相关化合物诱导的DNA弯曲幅度约为14 - 19度,这相当于长度约为5 - 6个碱基对的腺嘌呤 - 胸腺嘧啶序列产生的弯曲幅度。使用含有一个腺嘌呤序列和一个独特的(+)-CC-1065键合位点且两者相隔约一个螺旋圈的寡聚物进行的实验表明,药物诱导弯曲的方向是朝向小沟,弯曲位点位于共价修饰腺嘌呤5'侧约2 - 3个碱基对处。环化效率测定表明,(+)-CC-1065及相关药物产生的最佳环大小在168至180个碱基对之间。结合(+)-CC-1065对DNA序列选择性的分子基础对这些结果进行了讨论,并将(+)-CC-1065诱导的DNA弯曲与腺嘌呤序列相关的固有弯曲进行了比较。由于(+)-CC-1065对局部DNA结构产生的影响似乎与腺嘌呤序列和某些DNA结合蛋白自然产生的影响相似,因此考虑了这种现象与(+)-CC-1065及相关药物生物学效应的相关性。